dailyexpress.com.my ·
energy supply crisis medicine prices stable this year says dzulkefly
Topic context
This topic has been covered 339802 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedMalaysia-specific pharmaceutical sector: manufacturers absorbing cost increases (fuel, logistics) to keep medicine price rises minimal (1-2%). MoU for API and medical device raw material security suggests proactive supply chain management. No direct scarcity or margin squeeze identified; mechanism is cost absorption with government support. Impact is country-specific, not global.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Medicine prices to remain stable in Malaysia this year with potential increases of only 1-2%.
- Manufacturers absorb rising production and logistics costs due to increased fuel prices.
- Government signed MoU to secure raw materials for medical devices and Active Pharmaceutical Ingredients (API).
- Malaysian Organisation of Pharmaceutical Industries (MOPI) and originator drug manufacturers support price stability.
